Al-Ghezi, Zinah Zamil, et al. "Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome." Brain, behavior, and immunity 82 (2019): 25-35.
Almogi-Hazan, Osnat, and Reuven Or. "Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back." International journal of molecular sciences 21.12 (2020): 4448.
Ambrożewicz, Ewa, et al. "Pathophysiological alterations of redox signaling and endocannabinoid system in granulocytes and plasma of psoriatic patients." Cells 7.10 (2018): 159.
Blake, David R., et al. "Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis." Rheumatology 45.1 (2006): 50-52.
Centonze, Diego, et al. "The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis." Brain 130.10 (2007): 2543-2553.
Chan, Andrew, and Carlos Vila Silván. "Evidence-based management of multiple sclerosis spasticity with nabiximols oromucosal spray in clinical practice: a 10-year recap." Neurodegenerative disease management 12.3 (2022): 141-154.
Charoenying, T., Lomwong, K., Boonkrong, P., & Kruanamkam, W. (2023). Therapeutic potential of topical cannabis for the treatment of psoriasis: a preliminary clinical evaluation of two different formulations. Journal of Current Science and Technology, 14(1), Article 6.
Cuddihey, Hailey, Wallace K. MacNaughton, and Keith A. Sharkey. "Role of the endocannabinoid system in the regulation of intestinal homeostasis." Cellular and molecular gastroenterology and hepatology 14.4 (2022): 947-963.
de Fátima dos Santos Sampaio, Maria, et al. "Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders." Basic & Clinical Pharmacology & Toxicology 134.5 (2024): 574-601.
Del Río, Carmen, et al. "The endocannabinoid system of the skin. A potential approach for the treatment of skin disorders." Biochemical pharmacology 157 (2018): 122-133
Dubey, Preeti. Stability Analysis and simulation of deterministic models in epidemiology and immunology. Diss. BITS, Pilani, 2016.
Filippini, Graziella, et al. "Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis." Cochrane Database of Systematic Reviews 5 (2022).
Fukuda, Shin, et al. "Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis." BMC musculoskeletal disorders 15 (2014): 1-10.
Giorgi, Valeria, et al. "Cannabis and autoimmunity: possible mechanisms of action." ImmunoTargets and therapy (2021): 261-271.
Gruden G, Barutta F, Kunos G, Pacher P. Role of the endocannabinoid system in diabetes and diabetic complications. Br J Pharmacol. 2016 Apr;173(7):1116-27.
Gui, Huan, et al. "Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis." Immunobiology 220.6 (2015): 817-822.
Ismail, Morouj, and Ghada Khawaja. "Cannabinoid Receptor 2 Gene Polymorphism and the Risk of Developing Rheumatoid Arthritis in Lebanese Patients." Cannabis and Cannabinoid Research 9.6 (2024): e1597-e1603.
Kang, Hansol, et al. "Meta-analysis of the Therapeutic Impact of Cannabinoids in Inflammatory Bowel Disease." Inflammatory Bowel Diseases 31.2 (2025): 450-460
Katchan V, David P, Shoenfeld Y. Cannabinoids and autoimmune diseases: A systematic review. Autoimmun Rev. 2016;15(6):513-528. doi:10.1016/j.autrev.2016.02.008
Kozela, Ewa, et al. "Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis‐like disease in C57BL/6 mice." British journal of pharmacology 163.7 (2011): 1507-1519.
Lian, Jerome, Ilaria Casari, and Marco Falasca. "Modulatory role of the endocannabinoidome in the pathophysiology of the gastrointestinal tract." Pharmacological Research 175 (2022): 106025..
Lowin, T., Tingting, R., Zurmahr, J. et al. Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts. Cell Death Dis 11, 714 (2020).
Malfait, A. M., et al. "The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis." Proceedings of the National Academy of Sciences 97.17 (2000): 9561-9566.
Massa, F., Marsicano, G., Hermann, H., Cannich, A., Monory, K., Cravatt, B. F., Ferri, G. L., Sibaev, A., Storr, M., & Lutz, B. (2004). The endogenous cannabinoid system protects against colonic inflammation. Journal of Clinical Investigation, 113(8), 1202–1209.
Mecha, Miriam, et al. "Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: a role for A2A receptors." Neurobiology of disease 59 (2013): 141-150.
Mnekin L, Ripoll L. Topical use of cannabis sativa L. Biochem Cosme. 2021;8:85. doi:10.3390/cosmetics8030085
Naftali, Timna, et al. "Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study." Clinical Gastroenterology and Hepatology 11.10 (2013): 1276-1280.
Nso, Nso, et al. "Cannabis and its potential protective role against inflammatory bowel disease: a scoping review." Cureus 13.10 (2021).
Navarini, Luca, et al. "Endocannabinoid system in systemic lupus erythematosus: First evidence for a deranged 2-arachidonoylglycerol metabolism." The International Journal of Biochemistry & Cell Biology 99 (2018): 161-168.
Pagano, Cristina, et al. "Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris." Frontiers in Immunology 15 (2024): 1373435.
Rahaman, Oindrila, and Dipyaman Ganguly. "Endocannabinoids in immune regulation and immunopathologies." Immunology 164.2 (2021): 242-252.
Richardson, D., Pearson, R.G., Kurian, N. et al. Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis. Arthritis Res Ther 10, R43 (2008).
Rossi, Francesca, et al. "The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention." Pharmacological Research 66.1 (2012): 88-94.
Schlosburg JE, Blankman JL, Long JZ, et al. Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci. 2010;13:1113–1119. doi:10.1038/nn.2616
Shaw, Christian, L. L. C. Halcyon Therapeutics, and Jahan Marcu. "Cannabidiol in the Management of Comorbid Rheumatoid Arthritis, Lupus, and Raynaud’s Disease." Pain 2.30 (2016).
Sipe, Jack C., et al. "Reduced endocannabinoid immune modulation by a common cannabinoid 2 (CB2) receptor gene polymorphism: possible risk for autoimmune disorders." Journal of leukocyte biology 78.1 (2005): 231-238.
Ständer S, Schmelz M, Metze D, Luger T, Rukwied R. Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin. J Dermatol Sci. 2005;38:177–188. doi:10.1016/j.jdermsci.2005.01.007
Stella, Alessandro, et al. "A therapeutic effect of cbd-enriched ointment in inflammatory skin diseases and cutaneous scars." La Clinica Terapeutica 170.2 (2019): e93-e99.
Tan, Kyle BC, et al. "Anti-inflammatory effects of phytocannabinoids and terpenes on inflamed Tregs and Th17 cells in vitro." Experimental and Molecular Pathology 139 (2024): 104924.
Tian, Na, et al. "Cannabinoid receptor 2 selective agonist ameliorates adjuvant-induced arthritis by modulating the balance between Treg and Th17 cells." Frontiers in Pharmacology 16 (2025): 1532518.
Wei, Chaochao, et al. "Selective activation of cannabinoid receptor 2 regulates Treg/Th17 balance to ameliorate neutrophilic asthma in mice." Annals of Translational Medicine 9.12 (2021): 1015.
Wilkinson JD, Williamson EM. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis. J Dermatol Sci. 2007;45:87–92. doi:10.1016/j.jdermsci.2006.10.009
